Auteurs

Tasmina Goraya, PhD

Associé

Read More

Katie Chandler

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Agnieszka Sztoldman

Collaborateur senior

Read More
Auteurs

Tasmina Goraya, PhD

Associé

Read More

Katie Chandler

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Agnieszka Sztoldman

Collaborateur senior

Read More

20 février 2020

National perspectives on the CJEU Bayer decision

This month in Synapse

National perspectives on the CJEU Bayer decision

Our European team looks at what the CJEU decision in case C-688/17 may mean for national practice.

Medical devices and managing product liability risks

We look at medical device product liability, starting with an incident report to a regulator and following the potential issues that a manufacturer might face.

Clash of IP and competition to pharma's detriment? The CJEU's decision in theGSK case

Paolo Parmigiano and Barbora Dubanská explore the latest CJEU judgment in relation to pay-for-delay settlement agreements.

To Neurim or not to Neurim, that is the question

Anja Lunze examines what the Opinion of Advocate General Giovanni Pitruzella says concerning supplementary protection certificates.

Changes in the industrial property law of Poland

Kalina Skwiecińska and Agnieszka Sztoldman provide an overview of the changes to Polish industrial property law that recently came into effect.

Pricing: highlights of the J.P. Morgan Healthcare Conference

Barbora Dubanská reports on what the conference had to say about a major healthcare hot topic – drug pricing.

Patents diary: February 2020

A CRISPR Cas9 patent has its priority rejected by the Technical Board of Appeal, and there is a rare and successful application of the Crown use defence to infringement in the UK.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Brevets et innovation

English patent torpedoes and the UPC

19 juillet 2021
Quick read

par Paul England, DPhil

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Has there been a shift in how the European courts approach preliminary injunctions?

19 mai 2021
Quick read

par Paul England, DPhil et Christoph de Coster, LL.M. (UC Davis)

Cliquer ici pour en savoir plus
Technologie, Médias et Communications (TMC)

AI driven drug design

7 mai 2021
Quick read

par Paul England, DPhil

Cliquer ici pour en savoir plus